This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
12 results for: cbd
post featured image
The Portuguese National Authority for Medications and Health Products (INFARMED) issued a bulletin on the topic of the usage of cannabis...
post featured image
In an expected order of 24 January 2022, the interim relief judge of the French Administrative Supreme Court (Conseil d’Etat – “CE”)...
post featured image
Cannabis remains a controlled substance in most jurisdictions, but demand for medicinal and wellbeing cannabis products and their...
post featured image
On 15 December 2020, the Australian Therapeutic Goods Administration (TGA) published its decision to down-schedule certain low dose...
post featured image
As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...
post featured image
The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...
post featured image
The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...
post featured image
We previously reported in our article “Developments in Australian CBD market” that the Pharmaceutical Benefits Advisory Committee (PBAC)...
post featured image
The Australian Government has moved to further bolster the local cannabis industry with the passing of the Export Control Legislation...
post featured image
The cannabidiol (CBD) medicine market in Australia is set to grow. At present, there are no medicinal CBD products registered on the...
post featured image
The Therapeutic Goods Administration (TGA) – Australia’s regulatory body for pharmaceuticals and medical devices – is proposing to...
post featured image
By Rahool Sarjua and Kahwing Fung, 13 February 20202019 was a big year for cannabidiol (CBD) based products with new products appearing...